Switch to:

Regeneron Pharmaceuticals Interest Coverage

: 67.67 (As of Jun. 2020)
View and export this data going back to 1991. Start your Free Trial

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Regeneron Pharmaceuticals's Operating Income for the three months ended in Jun. 2020 was $656 Mil. Regeneron Pharmaceuticals's Interest Expense for the three months ended in Jun. 2020 was $-10 Mil. Regeneron Pharmaceuticals's interest coverage for the quarter that ended in Jun. 2020 was 67.67. The higher the ratio, the stronger the company's financial strength is.

NAS:REGN' s Interest Coverage Range Over the Past 10 Years
Min: 10.1   Med: 78.01   Max: 184.82
Current: 91.44

10.1
184.82

NAS:REGN's Interest Coverage is ranked lower than
53% of the 309 Companies
in the Biotechnology industry.

( Industry Median: 125.64 vs. NAS:REGN: 91.44 )

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Regeneron Pharmaceuticals Interest Coverage Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Regeneron Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Interest Coverage Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.91 184.82 82.85 89.87 73.17

Regeneron Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Interest Coverage Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.45 94.68 100.85 114.77 67.67

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Regeneron Pharmaceuticals Interest Coverage Distribution

* The bar in red indicates where Regeneron Pharmaceuticals's Interest Coverage falls into.



Regeneron Pharmaceuticals Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt.


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Regeneron Pharmaceuticals's Interest Coverage for the fiscal year that ended in Dec. 2019 is calculated as

Here, for the fiscal year that ended in Dec. 2019, Regeneron Pharmaceuticals's Interest Expense was $-30 Mil. Its Operating Income was $2,210 Mil. And its Long-Term Debt & Capital Lease Obligation was $714 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2019 )/Interest Expense (A: Dec. 2019 )
=-1*2209.8/-30.2
=73.17

Regeneron Pharmaceuticals's Interest Coverage for the quarter that ended in Jun. 2020 is calculated as

Here, for the three months ended in Jun. 2020, Regeneron Pharmaceuticals's Interest Expense was $-10 Mil. Its Operating Income was $656 Mil. And its Long-Term Debt & Capital Lease Obligation was $716 Mil.

Interest Coverage=-1* Operating Income (Q: Jun. 2020 )/Interest Expense (Q: Jun. 2020 )
=-1*656.4/-9.7
=67.67

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

The higher the ratio, the stronger the company's Financial Strength is.


Regeneron Pharmaceuticals  (NAS:REGN) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Regeneron Pharmaceuticals Interest Coverage Related Terms


Regeneron Pharmaceuticals Interest Coverage Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)